NEW DELHI: In the wake of shortage of oxygen and Covid-19 management drugs because of the sudden rise in Covid cases, Delhi government has directed drug inspectors to personally monitor the sale and stock of Remdesivir, Tocilizumab and Favipiravir in the city and deputed nine of its officers to oversee procurement and distribution of oxygen.
Delhi government has also set up control rooms to facilitate general public for getting drugs for Covid management. Two helpline numbers have been opened for those in need of Remdesivir or other drugs. For East, North East, South, Central, New Delhi, North districts, people can dial 011-22393705 while people can dial 9494129281/ 9000098558 for North West, South West and West districts. People from the other districts can dial any of these numbers.
The nine officers have been tasked to submit a report on daily basis on distribution of medical oxygen to various hospitals and nursing homes in Delhi, and on the procurement process of medical oxygen by filler agency. Chief minister Arvind Kejriwal and deputy CM Manish Sisodia had sounded alarm on the shortage of oxygen on Sunday and urged the central government to supply required oxygen to Delhi.
A spurt in demand for Remdesivir and other drugs has been witnessed recently. An order issued by the drugs control department of Delhi government stated that the drug inspectors would be personally liable for end-to-end monitoring of Remdesivir injection and any deviation from it would be viewed seriously and attract stringent action. The drug inspectors have been asked to submit a daily report on sale and distribution of Remdesivir.
“Every attempt is being made to make available Covid management drugs in all the major hospitals and company distribution outlets. In case of any difficulty in finding the source for procurement of Covid management drugs, any person may contact on the helpline numbers for any further inquiry,” the order stated.
“All the drug inspectors have been directed to personally oversee the whole procurement process of Remdesivir injection, starting from placement of order and its receipt by the distributor from the company depot, to ensure that all the supplies received by the distributors are entered in their relevant records and all the inventories made are properly accounted for. They will also ensure that all the relevant records of sale and distribution of Remdesivir formulations are properly maintained and retained according to the relevant provisions of Drugs & Cosmetics Act, 1940,” the order stated further.
The central government has granted permission to manufacture and market the Covid-19 management drug Remdesivir for restricted emergency use to some companies and the permission is subject to various conditions and restrictions.